Final NR 566 Test Questions with Verified Answers (Correct
Update)
Question 1: Khalil is an ENTB who regularly screens his clients for substance use disorders to
ensure early intervention. Recently, he has been focusing on improving the screening process for
alcohol use disorder by identifying clients who may be engaging in harmful drinking patterns.
Esmeralda is a 45-year-old female client who presents to the clinic for a routine checkup. She
admits to drinking socially and has no current complaints. Her vital signs and physical exam are
normal and she has no past medical history. To assess her alcohol consumption more accurately,
which validity screening tools should Khalil employ?
Answer: Alcohol Use Disorder Identification Test (AUDIT)
Question 2: Luca, a 35-year-old male client, presents to the clinic for a checkup. Luca has no
complaints or significant medical history, and his vital signs and physical exam are normal.
Oksana, the nurse practitioner, uses the audit to screen him to alcohol use disorder. Luca's
response indicates a moderate risk of alcohol dependence. Oksana decides to conduct a
comprehensive assessment to understand better Luca's drinking behavior and its impact on his
life. Following a positive audit screened for alcohol use disorder, which of the following is the
next best step for Oksana to take in assessing Luca?
Answer: Conduct a detailed medical and social history to understand the context of Luca's alcohol use.
Question 3: Jamal is a 50-year-old male client with a past medical history of asthma. He has been
diagnosed with opioid use disorder and is currently using opioids, but wishes to stop. His
provider is considering FDA-approved medication to help manage his condition and reduce his
dependence on opioids. Which FDA-approved medication should Jamal's provider consider
ordering to help manage his OUD and reduce potential withdrawal symptoms?
Answer: Methadone
Question 4: Tom is a 61-year-old male client with a past medical history of significant for high
cholesterol. He has been diagnosed with major depressive disorder and has a history of heavy
alcohol use, which he uses to cope with his depression. He recently began using opioids as well.
He wishes to stop abusing alcohol and opiates. Which of the following medication is appropriate
for managing both Tom's substance abuse issues?
Answer: Vivitrol
Page 1
, Question 5: Ella Nguyen is a 19-year-old female client who was Explain in a car accident four
years ago and began using high doses of opioid pain medications to manage the injuries she
sustained. She has been prescribed naloxone due to her risk factors associated with opioid use
disorder. Her family is concerned and wants to understand how they can help prevent potential
overdoses. Which of the following should be included when educating Ella Nguyen's family about
safety and overdose prevention?
Answer: how to recognize signs of opioid overdose and how to administer naloxone.
Question 6: Jamal is a 50-year-old male client with a past medical history of asthma. He has been
diagnosed with opioid use disorder and is currently using opiopioid oids but wishes to stop. His
provider is considering FDA-approved medications to help manage his is condition and reduce
his dependence on opioids. Which FDA-approved medications should Jamal's provider consider
ordering to help manage his OUD and reduce potential withdrawal symptoms
Answer: Subutex (buprenorphine) is an FDA-approved medication for use disorder (OUD) that can be
started while the patient in mild to moderate withdrawal. It reduces cravings and withdrawal symptoms,
Question 7: A patient with bipolar disorder is being started on lithium therapy. What baseline
data should be assessed before initiating lithium treatment?
Answer: Electrocardiogram, comprehensive metabolic panel, and thyroid function test.
Question 8: Which factor primarily influences selection of anti- Tolerability depressants among
drugs with nearly equal efficacy?
Answer: and safety profile
Question 9: A patient with depression presents with significant somnolence after starting
mirtazapine therapy. Which of the following measures should be taken to manage this side
effect?
Answer: Adjust the mirtazapine dosage
Question 10: A patient with major depression has not responded Monoamine to treatment with
SSRI or TCAs. What alternative medication option should the healthcare provider consider?
Answer: oxidase inhibitors (MAOIs)
Question 11: A patient taken an MAOI and is prescribed Venlafaxine for another medical
condition, what should the healthcare provider do with the MAOI?
A. Discontinue Venlafaxine and continue the MAOI since it is the most important medication.
Answer: Stop the MAOI for at least 14 days before starting venlafaxine
Page 2
Update)
Question 1: Khalil is an ENTB who regularly screens his clients for substance use disorders to
ensure early intervention. Recently, he has been focusing on improving the screening process for
alcohol use disorder by identifying clients who may be engaging in harmful drinking patterns.
Esmeralda is a 45-year-old female client who presents to the clinic for a routine checkup. She
admits to drinking socially and has no current complaints. Her vital signs and physical exam are
normal and she has no past medical history. To assess her alcohol consumption more accurately,
which validity screening tools should Khalil employ?
Answer: Alcohol Use Disorder Identification Test (AUDIT)
Question 2: Luca, a 35-year-old male client, presents to the clinic for a checkup. Luca has no
complaints or significant medical history, and his vital signs and physical exam are normal.
Oksana, the nurse practitioner, uses the audit to screen him to alcohol use disorder. Luca's
response indicates a moderate risk of alcohol dependence. Oksana decides to conduct a
comprehensive assessment to understand better Luca's drinking behavior and its impact on his
life. Following a positive audit screened for alcohol use disorder, which of the following is the
next best step for Oksana to take in assessing Luca?
Answer: Conduct a detailed medical and social history to understand the context of Luca's alcohol use.
Question 3: Jamal is a 50-year-old male client with a past medical history of asthma. He has been
diagnosed with opioid use disorder and is currently using opioids, but wishes to stop. His
provider is considering FDA-approved medication to help manage his condition and reduce his
dependence on opioids. Which FDA-approved medication should Jamal's provider consider
ordering to help manage his OUD and reduce potential withdrawal symptoms?
Answer: Methadone
Question 4: Tom is a 61-year-old male client with a past medical history of significant for high
cholesterol. He has been diagnosed with major depressive disorder and has a history of heavy
alcohol use, which he uses to cope with his depression. He recently began using opioids as well.
He wishes to stop abusing alcohol and opiates. Which of the following medication is appropriate
for managing both Tom's substance abuse issues?
Answer: Vivitrol
Page 1
, Question 5: Ella Nguyen is a 19-year-old female client who was Explain in a car accident four
years ago and began using high doses of opioid pain medications to manage the injuries she
sustained. She has been prescribed naloxone due to her risk factors associated with opioid use
disorder. Her family is concerned and wants to understand how they can help prevent potential
overdoses. Which of the following should be included when educating Ella Nguyen's family about
safety and overdose prevention?
Answer: how to recognize signs of opioid overdose and how to administer naloxone.
Question 6: Jamal is a 50-year-old male client with a past medical history of asthma. He has been
diagnosed with opioid use disorder and is currently using opiopioid oids but wishes to stop. His
provider is considering FDA-approved medications to help manage his is condition and reduce
his dependence on opioids. Which FDA-approved medications should Jamal's provider consider
ordering to help manage his OUD and reduce potential withdrawal symptoms
Answer: Subutex (buprenorphine) is an FDA-approved medication for use disorder (OUD) that can be
started while the patient in mild to moderate withdrawal. It reduces cravings and withdrawal symptoms,
Question 7: A patient with bipolar disorder is being started on lithium therapy. What baseline
data should be assessed before initiating lithium treatment?
Answer: Electrocardiogram, comprehensive metabolic panel, and thyroid function test.
Question 8: Which factor primarily influences selection of anti- Tolerability depressants among
drugs with nearly equal efficacy?
Answer: and safety profile
Question 9: A patient with depression presents with significant somnolence after starting
mirtazapine therapy. Which of the following measures should be taken to manage this side
effect?
Answer: Adjust the mirtazapine dosage
Question 10: A patient with major depression has not responded Monoamine to treatment with
SSRI or TCAs. What alternative medication option should the healthcare provider consider?
Answer: oxidase inhibitors (MAOIs)
Question 11: A patient taken an MAOI and is prescribed Venlafaxine for another medical
condition, what should the healthcare provider do with the MAOI?
A. Discontinue Venlafaxine and continue the MAOI since it is the most important medication.
Answer: Stop the MAOI for at least 14 days before starting venlafaxine
Page 2
